Electronic Health Records Market Predicted to Witness Steady Growth During the Forecast Period: Grand View Research Inc.

San Francisco, 4 February 2019: The Report Electronic Health Records (EHR) Market Analysis By Product (Client Server-based, Web-based), By Type (Acute, Ambulatory, Post-Acute) By End-use (Hospitals, Ambulatory Care), And Segment Forecasts, 2018 - 2025

The global Electronic Health Records (EHR) market is expected to reach USD 33.41 billion by 2025, according to a new report by Grand View Research, Inc. The government initiatives undertaken in support of EHR adoption are most likely to accentuate the market growth. 

The federal government introduced Health Information Technology for Economic and Clinical Health (HITECH) Act in 2009 for promoting usage of EHR amongst healthcare providers. The program included provision of training and assistance for health information technology (IT) workers in order to set up EHRs in the hospitals. 

The National Health Services (NHS), UK is planning to convert the documentation process into digitized form completely by the year 2018. In the U.S., federal government has announced financial incentives for physicians planning to adopt EHR systems. Any average physician with at least 30% of his/her patients covered with Medicare is eligible for incentives worth USD 44,000. 

Many region-specific initiatives are promoting eHealth services. For instance, EUR-Lex gave eHealth action plan for 2012 – 2020, which states the strategies for deployment of eHealth services amongst European nations. 

Access Research Report of Electronic Health Records Market @ www.grandviewresearch.com/industry-analysis/electronic-health-records-ehr-market

Further Key Findings From The Report Suggest:

·       Web-based EHR was observed to be the largest product segment owing to the fact that it can be deployed without in-house installation of complex hardware infrastructure. Moreover, web-based EHR is expected to be the fastest growing product segment in the coming years

·       Acute care EHR held the majority of EHR type market share at around 48% in the year 2016; whereas post-acute care EHR is likely to showcase fastest growth rate over the forecast period

·       The hospital use EHR segment accounted for the largest end-use share due to the excessive adoption rate among hospitals, whereas ambulatory care EHR is expected to be the fastest growing segment

·       As a part of the Health HITECH Act of 2009, the federal government allocated USD 27 billion for an incentive program, especially arranged for promoting adoption of EHR in hospitals and ambulatory care centers

·       The EHR industry in Asia Pacific is projected to display substantial growth over the forecast period owing to various developments across major economies along with increased expenditure on healthcare IT. This regional market is expected to grow at a CAGR of 7% from 2017 to 2025

·       According to Healthcare Information and Management Systems Society (HIMSS) analysis adoption model for EHR, more than 2.5% of total hospitals in the Asia Pacific region crossed stage 6 of EHR implementation by the end of 2016, fueling the regional market growth

·       Some of the established key players in this industry include Cerner; Allscripts; McKesson Corporation; MEDITECH; Epic Systems Corporation; and NextGen Healthcare. Some of the emerging players are eClinicalWorks; Healthcare Management System; Healthland; and CureMD Healthcare; etc. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global EHR market on the basis of product, type, end-use, and region: 

Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Client Server-based EHR

·         Web-based EHR

Type Outlook (Revenue, USD Million, 2014 - 2025)

·         Acute EHR

·         Ambulatory EHR

·         Post-Acute EHR

End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals

·         Ambulatory Care

Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Access Press Release of Electronic Health Records Market@ www.grandviewresearch.com/press-release/global-electronic-health-records-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Erectile Dysfunction Drugs Market Set to Surge Significantly During the Forecast Period: Grand View Research Inc.

San Francisco, 4 February 2019: The Report Erectile Dysfunction Drugs Market Analysis By Product (Viagra, Levitra/Staxyn, Stendra/Spedra, Zydena, Vitaros), And Segment Forecasts To 2022

The global erectile dysfunction drugs market is expected to reach USD 3.2 billion by 2022 according to a new report by Grand View Research Inc. Rising adoption of sedentary lifestyle and increasing prevalence of conditions causing erectile dysfunction such as stress, hypertension, and related medications are the key factors expected to widen the target population base for this market. 

However, the market is estimated to witness decline in revenue over the forecast period. Expiration of key drugs from 2017 to 2019 is likely to curb revenue growth. On the other hand, the market is likely to open up new avenues for the generic manufacturers to capitalize on. The increasing risk of sexually transmitted diseases, narrowing of insurance coverage for erectile dysfunction treatment, growing threat from counterfeit drugs, and presence of social stigma in developing countries are some factors limiting penetration rates. 

Access Research Report of Erectile Dysfunction Drugs Market @ www.grandviewresearch.com/industry-analysis/erectile-dysfunction-drugs-market

Further key findings from the report suggest:

·       Viagra accounted for over 47.0% of the total revenue in 2014. It is generally considered as the first line of treatment for erectile dysfunction. Brand loyalty and advantages associated with this drug such as high efficacy, and effectiveness are the major factors attributing for its large market share.

·       Cialis (tadalafil) from Eli Lilly & Co. and Levitra (vardenafil) from Bayer AG are known to be the competitors for Viagra globally. Cialis (tadalafil) was approved in 2003 by the U.S. FDA, as a prescription drug in the U.S. Cialis is also known as “The Weekend Pill” owing to its 36-hour effectiveness.

·       After the patent expiration of key drugs such as Cialis (tadalafil) in 2017 and Levitra (vardenafil) in 2018, other drugs such as Stendra/Spedra, Zydena (udenafil), and Vitaros (Alprostadil Cream) are expected to capture the market share during the forecasts period.

·       North America constituted the largest share of approximately 55.0% in 2013 of the total erectile dysfunction market. Extension of patent exclusivity rights for Viagra (sildenafil citrate) in the U.S. till 2019 along with introduction of new erectile dysfunction drugs such as Zydena (udenafil) and Stendra/Spedra (avanafil) will be the major factors responsible for market growth during the forecasts period.

·       Asia Pacific accounted for a revenue share of over 16.5% in 2012 owing to the presence of a lucrative market for generic drugs, untapped opportunities, and increasing awareness related to erectile dysfunction in this region

·       Apricus Biosciences Inc., Cristalia Produtos Quimicos Farmaceuticos Ltd., Bayer AG, Dong-A Pharmaceutical Co. Ltd., Meda Pharmaceuticals, Inc., Eli Lilly and Company, Pfizer, Inc., S.K. Chemicals Co. Ltd., and Vivus, Inc. are some major players of this market

·       Extensive R&D carried out by companies and high unmet needs in developing economies are expected to boost industrial growth. Key manufacturers are targeting regions with unmet clinical needs by entering into agreement with local manufacturers and distributors. Key players are constantly engaged in developing novel drugs in an attempt to improve the presence and ensure sustainability. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global erectile dysfunction drugs market on the basis of product and region:

Erectile Dysfunction Drugs Product Outlook (Revenue, USD Million, 2012 - 2022)

·         Viagra (sildenafil citrate)

·         Cialis (tadalafil)

·         Levitra/Staxyn (vardenafil)

·         Stendra/Spedra (avanafil)

·         Zydena (udenafil)

·         Vitaros (Alprostadil Cream)

·         Others

Erectile Dysfunction Drugs Regional Outlook (Revenue, USD Million, 2012 - 2022)

·         North America

·         Europe

·         Asia Pacific

·         RoW

Access Press Release of Erectile Dysfunction Drugs Market@ www.grandviewresearch.com/press-release/global-erectile-dysfunction-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Ambulance Services Market to Account for USD 48.9 Billion by 2025: Grand View Research Inc.

San Francisco, 4 February 2019: The Report Ambulance Services Market Analysis by Transport Vehicle (Ground, Air, Water), by Emergency Services (Emergency & Non-Emergency), by Equipment (Advance & Basic Life Support (ALS & BLS)), and Segment Forecasts, 2018 - 2025

The global ambulance services market is anticipated to reach USD 48.9 billion by 2025, according to a new report by Grand View Research, Inc. Increasing geriatric population prone to cardiovascular diseases, favorable reimbursement policies, rising medical tourism, and increasing number of road accidents are the key factors that are driving the market growth.

The ambulance services market growth is anticipated to increase due to favorable reimbursement policies in the developed nations. In the U.S., Medicare covers both emergency and non-emergency ambulance services, if it is considered medically necessary and the supplier fulfills Medicare ambulance requirements.

However, Medicare does not pay for the ambulette services. In Victoria, Australia, patients can avail ambulance services by securing a membership with Ambulance Victoria which also protects the patient from the high cost of ambulance services. In Tasmania, the Ambulance Tasmania provides free ambulance services to Tasmanian residents within Tasmania only. All Queensland (Australia) residents are covered for the cost of emergency services across Australia, by the QLD state government. In the rest of the Australia, subscription to various ambulance services covers the emergency as well as non-emergency ambulance services. Similarly, in the UK, public healthcare system provides free emergency and non-emergency ambulance services. Thus, the favorable reimbursement policies are driving the growth of the market.

Access Research Report of Ambulance Services Market @ www.grandviewresearch.com/industry-analysis/ambulance-services-market

Further Key Findings From the Study Suggest:

·       Ground ambulance services accounted for the largest share in 2016 owing to the effectiveness and common usage of these ambulance services.

·       Emergency services is anticipated to dominate the market in the forecast period. The growth of this segment can be attributed to the increasing prevalence of cardiovascular diseases.

·       Advanced Life Support (ALS) ambulance services is anticipated to dominate the market in the forecast period. The growth of this segment can be attributed to rising dependence on life support services among patient, high number of cardiovascular incidents, and increase in technologically advanced equipment and trained personnel.

·       Asia Pacific ambulance services market is expected to grow with the highest CAGR over the forecast period

·       Major players of the market include, Envision Healthcare Corporation, London Ambulance Service NHS Trust, BVG India Ltd., America Ambulance Services, Inc., Falck Holding A/S, and Medivic Aviation.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global ambulance services market on the basis of transport vehicle, emergency services, equipment, and region:

Transport Vehicle Outlook (Revenue, USD Million, 2014 - 2025)

·         Ground Ambulance

·         Air Ambulance

·         Water Ambulance

Emergency Services Outlook (Revenue, USD Million, 2014 - 2025)

·         Emergency Services

·         Non-Emergency Services

Equipment Outlook (Revenue, USD Million, 2014 - 2025)

·         Basic Life Support (BLS) Ambulance Services

·         Advanced Life Support (ALS) Ambulance Services

Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa (MEA)

Access Press Release of Ambulance Services Market@ www.grandviewresearch.com/press-release/global-ambulance-services-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Diabetic Foot Ulcer Treatment Market Growth With Worldwide Industry Analysis To 2025: Grand View Research Inc.

San Francisco, 4 February 2019: The Report Diabetic Foot Ulcer (DFU) Treatment Market Analysis Report By Treatment (Biologics, Wound Care Dressings, Therapy Devices), By Ulcer Type (Ischemic, Neuro-Ischemic, Neuropathic), And Segment Forecasts, 2019 - 2025

The global diabetic foot ulcer treatment market size is expected to reach a value of USD 6.82 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.2% during the forecast period. Rising prevalence of diabetes, increasing healthcare expenses, and rapidly growing geriatric population worldwide are some of the major factors driving the diabetic foot ulcer treatment market.

Diabetic foot ulcers are one of the most common foot injuries that is caused due to diabetes mellitus. Management of diabetic foot ulcers aims at fast healing and wound closure, by adopting a multidisciplinary therapeutic approach so as to avoid amputation. Among different types of treatment options available, biologics held the largest share in the diabetic foot ulcer treatment market in 2017. This can be attributed to strong revenue generated by growth factors that are prescribed worldwide for their ability to promote generation of new cells and achieve wound closure. Therapy devices and wound care dressings also offer significant commercial opportunity due to their cost-effectiveness, ease of availability, and wide use in combination with other treatments at every level of wound care management.

Among different ulcer types, neuro-ischemic ulcers led the market in 2017 with more than 50.0% market share due to higher patient population suffering from the ulcer type globally. North America represented the largest share in the global market in 2017 owing to rising prevalence of diabetes, growing geriatric cohort, increased investment in R&D of novel therapies, and developed healthcare facilities.

Access Research Report of Diabetic Foot Ulcer Treatment Market @ www.grandviewresearch.com/industry-analysis/diabetic-foot-ulcer-dfu-treatment-market

Further Key Findings From the Study Suggest:

·       The biologics segment commanded the largest share in 2017 and is projected to retain its position through the forecast period, due to increased adoption and potential approvals of growth factors

·       North America dominated the DFU treatment market in 2017 due to well-established favorable healthcare reimbursements and infrastructure

·       Asia Pacific is expected to witness the fastest growth owing to expanding diabetes patient population driven by increasing healthcare expenses and growing geriatric cohort

·       The neuro-ischemic ulcers segment accounted for the leading share in 2017. It is likely to experience the fastest growth during the forecast period

·       The foam and alginate dressings, skin grafts, and negative pressure wound therapy segments are anticipated to exhibit significant CAGR over the forecast period

·       Some of the key players in this space are ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast A/S; Smith & Nephew Plc.; B. Braun Melsungen AG; Medline Industries, Inc.; Medtronic Plc.; Organogenesis, Inc.; Molnlycke Health Care AB; and BSN Medical GMBH.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global diabetic foot ulcer (DFU) treatment market on the basis of treatment, ulcer type, and region:

Diabetic Foot Ulcer (DFU) Treatment Outlook (Revenue, USD Million, 2016 - 2025)

·         Wound Care Dressings

·         Biologics

·         Therapy Devices

·         Antibiotic Medications

·         Others

Diabetic Foot Ulcer (DFU) Treatment Ulcer Type Outlook (Revenue, USD Million, 2016 - 2025)

·         Neuropathic Ulcers

·         Ischemic Ulcers

·         Neuro-ischemic Ulcers

Diabetic Foot Ulcer (DFU) Treatment Region Outlook (Revenue, USD Million, 2016 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Diabetic Foot Ulcer Treatment Market@ www.grandviewresearch.com/press-release/global-diabetic-foot-ulcer-dfu-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com